IN8BIO, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Rochlin Kate | Chief Operating Officer | Award / Grant | 7,247 | $1.38 | $10,001 | 9,085 | Dec 22, 2025 |
| McCall Patrick | CHIEF FINANCIAL OFFICER | Award / Grant | 7,247 | $1.38 | $10,001 | 9,482 | Dec 22, 2025 |
| Ho William Tai-Wei | PRESIDENT AND CEO | Award / Grant | 36,232 | $1.38 | $50,000 | 121,168 | Dec 22, 2025 |
| Roemer Alan S. | — | Award / Grant | 36,232 | $1.38 | $50,000 | 49,514 | Dec 22, 2025 |
| Brandt Peter C. | — | Award / Grant | 72,464 | $1.38 | $100,000 | 95,181 | Dec 22, 2025 |
| FAIRBAIRN EMILY | — | Award / Grant | 724,637 | $1.38 | $999,999 | 724,637 | Dec 22, 2025 |
| Rochlin Kate | Chief Operating Officer | Option Exercise | 12,295 | $0.18 | $2,213 | 55,169 | Apr 30, 2025 |
| McCall Patrick | CHIEF FINANCIAL OFFICER | Option Exercise | 15,000 | $0.18 | $2,700 | 67,071 | Apr 30, 2025 |
| Roemer Alan S. | — | Option Exercise | 102,459 | $0.18 | $18,443 | 387,489 | Apr 30, 2025 |
| Brandt Peter C. | — | Option Exercise | 81,967 | $0.18 | $14,754 | 681,538 | Apr 30, 2025 |
| Rochlin Kate | Chief Operating Officer | Award / Grant | 25,316 | — | — | 42,874 | Oct 4, 2024 |
| McCall Patrick | CHIEF FINANCIAL OFFICER | Award / Grant | 25,316 | — | — | 52,071 | Oct 4, 2024 |
| Roemer Alan S. | — | Award / Grant | 126,582 | — | — | 285,030 | Oct 4, 2024 |
| Brandt Peter C. | — | Award / Grant | 253,164 | — | — | 517,604 | Oct 4, 2024 |
| Ho William Tai-Wei | PRESIDENT AND CEO | Award / Grant | 126,582 | — | — | 2,548,094 | Oct 4, 2024 |
| Graff Jeremy R. | — | Award / Grant | 2,049 | — | — | 4,549 | Dec 13, 2023 |
| Epperly Corinne | — | Award / Grant | 81,967 | — | — | 81,967 | Dec 13, 2023 |
| Roemer Alan S. | — | Award / Grant | 102,459 | — | — | 158,448 | Dec 13, 2023 |
| Ho William Tai-Wei | President and CEO | Award / Grant | 81,967 | — | — | 2,421,512 | Dec 13, 2023 |
| McCall Patrick | Chief Financial Officer | Award / Grant | 20,492 | — | — | 26,755 | Dec 13, 2023 |
| Rochlin Kate | Chief Operating Officer | Award / Grant | 12,295 | — | — | 17,558 | Dec 13, 2023 |
| Goswami Trishna | Chief Medical Officer | Award / Grant | 4,098 | — | — | 6,729 | Dec 13, 2023 |
| Lamb Lawrence | EVP and CSO | Award / Grant | 1,639 | — | — | 101,369 | Dec 13, 2023 |
| Brandt Peter C. | — | Award / Grant | 81,967 | — | — | 264,440 | Dec 13, 2023 |
| Graff Jeremy R. | — | Purchase | 2,500 | $0.95 | $2,375 | 2,500 | Sep 13, 2023 |
| McCall Patrick | Chief Financial Officer | Purchase | 1,000 | $1.03 | $1,030 | 6,263 | Aug 25, 2023 |
| Ho William Tai-Wei | President and CEO | Purchase | 23,800 | $1.05 | $24,990 | 2,339,545 | Aug 24, 2023 |
| FAIRBAIRN EMILY | — | Other | 4,111,958 | — | — | — | Jul 28, 2023 |
| Kreis Leslie W. | — | Purchase | 8,735 | $2.48 | $21,663 | 570,724 | Dec 12, 2022 |
| BIOS Fund III QP, LP | — | Purchase | 8,735 | $2.48 | $21,663 | 570,724 | Dec 12, 2022 |
| BIOS Fund II NT, LP | — | Purchase | 2,913 | $2.02 | $5,884 | 561,989 | Sep 28, 2022 |
| Bios Equity Partners II, LP | — | Purchase | 2,913 | $2.02 | $5,884 | 561,989 | Sep 28, 2022 |
| BIOS Fund II QP, LP | — | Purchase | 4,660 | $2.02 | $9,413 | 559,076 | Aug 26, 2022 |
| Cavu Advisors, LLC | — | Purchase | 4,660 | $2.02 | $9,413 | 559,076 | Aug 26, 2022 |
| BIOS Fund II NT, LP | — | Purchase | 5,823 | $1.93 | $11,238 | 553,110 | Aug 17, 2022 |
| Cavu Management, LP | — | Purchase | 38,035 | $1.93 | $73,408 | 3,612,569 | Aug 17, 2022 |
| Transcend Partners Opportunity Fund LLC | — | Purchase | 789,473 | $1.90 | $1,499,999 | 4,111,958 | Aug 16, 2022 |
| Ho William Tai-Wei | President, CEO and CFO | Purchase | 26,315 | $1.90 | $49,999 | 2,315,745 | Aug 16, 2022 |
| Rochlin Kate | Chief Operating Officer | Purchase | 5,263 | $1.90 | $10,000 | 5,263 | Aug 16, 2022 |
| McCall Patrick | Chief Financial Officer | Purchase | 5,263 | $1.90 | $10,000 | 5,263 | Aug 16, 2022 |
| Goswami Trishna | Chief Medical Officer | Purchase | 2,631 | $1.90 | $4,999 | 2,631 | Aug 16, 2022 |
| Lamb Lawrence | EVP and CSO | Purchase | 526 | $1.90 | $999 | 99,730 | Aug 16, 2022 |
| Greenwood Luba | — | Purchase | 526 | $1.90 | $999 | 7,826 | Aug 16, 2022 |
| Roemer Alan S. | — | Purchase | 26,315 | $1.90 | $49,999 | 55,989 | Aug 16, 2022 |
| Brandt Peter C. | — | Purchase | 105,263 | $1.90 | $200,000 | 182,473 | Aug 16, 2022 |
| BIOS Fund II, LP | — | Purchase | 206,575 | $1.90 | $392,493 | 540,287 | Aug 16, 2022 |
| BIOS Advisors GP, LLC | — | Purchase | 206,575 | $1.90 | $392,493 | 540,287 | Aug 16, 2022 |
| Lamb Lawrence | EVP and CSO | Option Exercise | 26,204 | $1.07 | $28,038 | 99,204 | May 5, 2022 |
| BIOS Fund II NT, LP | — | C | 1,876,624 | — | — | 1,876,624 | Aug 3, 2021 |
| Ho William Tai-Wei | President, CEO and CFO | C | 3,070 | — | — | 72,999 | Aug 3, 2021 |